Pharmacogenetics - 24/08/11
Doi : 10.1016/j.pop.2004.04.009
Sean P. David, MD, SM 
Department of Family Medicine, Brown Medical School, Brown University Center for Primary Care and Prevention, 111 Brewster Street, Pawtucket, RI 02860, USA
Primary Care Genetics Laboratory and Translational Research Center, Memorial Hospital of Rhode Island USA
Department of Pharmacology, University of Oxford, Oxford, UK USA
Plan
 | This work is funded by the National Cancer Institute, Transdisciplinary Tobacco Use Research Center Grant, P50 CA84719. Additional funding provided by National Institute on Drug Abuse Grant 1 K08 DA14276-02, an Advanced Research Training Award from the American Academy of Family Physicians, Cancer Research UK, and a Robert Wood Johnson Foundation Generalist Physician Faculty Scholars Award. |
© 2004
Elsevier Inc. Tous droits réservés.
Vol 31 - N° 3
P. 543-559 - septembre 2004 Retour au numéro
Article précédent
- Legacy of the American eugenics movement: implications for primary care
- Michael Stehney
- What's new in prenatal screening and diagnosis?
- Jennifer A. Bubb, Anne L. Matthews
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?